A Multi-Center, Randomized, Placebo-Controlled Evaluation of the Safety and Efficacy of the KXL System With VibeX (Riboflavin Ophthalmic Solution) for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Phase of Trial: Phase III
Latest Information Update: 28 Jun 2017
At a glance
- Drugs Riboflavin (Primary)
- Indications Keratoconus
- Focus Registrational; Therapeutic Use
- Sponsors Avedro
- 20 Jun 2017 Status changed from active, no longer recruiting to discontinued.
- 23 Jan 2017 Planned End Date changed from 1 Dec 2016 to 1 Mar 2017.
- 27 Jun 2016 Planned End Date changed from 1 Mar 2016 to 1 Dec 2016.